Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 35Neoplasms 23Motor Activity 11Stomach Neoplasms 7Pain, Postoperative 7Lung Neoplasms 7Fatigue 7Colorectal Neoplasms 7Pain 5Anxiety Disorders 5Polycystic Ovary Syndrome 4Depression 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Stomatitis 3Sleep Initiation and Maintenance Disorders 3Rectal Neoplasms 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Malnutrition 3Liver Neoplasms 3Leukemia, Myeloid, Acute 3Colonic Neoplasms 3Agnosia 3Vomiting 2Urinary Incontinence 2Squamous Cell Carcinoma of Head and Neck 2Parasomnias 2Ovarian Neoplasms 2

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × Control Groups × Clear all
NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Simcere Pharmaceutical Co., Ltd

Phase 4 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡